2018 was a record year for biopharma initial public offerings (IPOs), with an all-time high of $6.3 billion raised by 58 U.S. companies as of December 17, according to Renaissance Capital, compared with 36 companies garnering some $4 billion in 2017.
{iframe}https://www.genengnews.com/a-lists/top-10-global-biopharma-ipos-of-2018/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20190114&ajs_uid=1673D8247356B7U&oly_enc_id=1673D8247356B7U&ajs_trait_oebid=9675B9130356B7S{/iframe}